4//SEC Filing
Talecris Biotherapeutics Holdings Corp. 4
Accession 0001223203-10-000260
CIK 0001405197operating
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 4:30 PM ET
Size
5.6 KB
Accession
0001223203-10-000260
Insider Transaction Report
Form 4
LYNCH THOMAS J
Sr. VP, Corp. Compliance
Transactions
- Sale
Common Stock
2010-09-03$22.50/sh−113,440$2,552,400→ 21,120 total
Footnotes (2)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2010.
- [F2]The number of shares reported includes restricted share units representing the right to receive 2,631 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
Documents
Issuer
Talecris Biotherapeutics Holdings Corp.
CIK 0001405197
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001405197
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 4:30 PM ET
- Size
- 5.6 KB